About this trial
This study is a prospective randomized controlled trial that aims to enroll 158 patients diagnosed with chronic hypertrophic rhinitis who are candidates for inferior turbinate surgery. Participants will be randomly assigned to either the "standard group" or the "PDA group." The standard group will receive conventional shared decision-making (SDM) explanations using verbal and visual aids, while the PDA group will additionally receive a printed patient decision aid (PDA) to assist in evaluating the pros and cons of each surgical option. The study will assess patients' decision certainty and decision regret using the SURE scale and the Decision Regret Scale (DRS), respectively, administered before surgery and one month postoperatively. Surgical satisfaction and outcomes will also be evaluated using pre- and postoperative symptom questionnaires. All data will be collected and analyzed by blinded outcome assessors to ensure objectivity. This study involves no invasive procedures and is classified as a low-risk behavioral study. The primary aim is to optimize clinical decision-making processes for patients with chronic hypertrophic rhinitis considering surgical intervention in the otolaryngology setting.
Eligibility criteria
Qualifiers
Diagnosed with chronic hypertrophic rhinitis.
Outpatients or inpatients scheduled to undergo surgical intervention.
Aged 18 years or older and able to communicate in Chinese.
Disqualifiers
Presence of other structural nasal pathologies (e.g., nasal polyps, tumors).
Patients undergoing emergency surgery.
Individuals unable to live independently or fully comprehend the questionnaire content.
Individuals unable to complete the questionnaires.
Trial design
Treatments tested in this trial
- Patient decision aid